Use este identificador para citar ou linkar para este item: http://repositorio.ufc.br/handle/riufc/32438
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorMaes, Michael M-
dc.contributor.authorBonifacio, Kamila Landucci-
dc.contributor.authorMorelli, Nayara Rampazzo-
dc.contributor.authorVargas, Heber Odebrecht V-
dc.contributor.authorMoreira, Estefânia Gastaldello-
dc.contributor.authorStoyanov, Drozdstoy St.-
dc.contributor.authorBarbosa, Décio Sabbatini-
dc.contributor.authorCarvalho, André F.-
dc.contributor.authorNunes, Sandra Odebrecht Vargas-
dc.date.accessioned2018-05-30T18:26:51Z-
dc.date.available2018-05-30T18:26:51Z-
dc.date.issued2018-05-
dc.identifier.citationMAES, M. et al. Generalized anxiety disorder (GAD) and comorbid major depression with GAD are characterized by enhanced nitro-oxidative stress, increased lipid peroxidation, and lowered lipid-associated antioxidant defenses. Neurotoxicity Research, p. 1–22, may. 2018.pt_BR
dc.identifier.issn1029-8428-
dc.identifier.issn1476-3524 (On line)-
dc.identifier.urihttp://www.repositorio.ufc.br/handle/riufc/32438-
dc.description.abstractAccumulating evidence shows that nitro-oxidative pathways play an important role in the pathophysiology of major depressive disorder (MDD) and bipolar disorder (BD) and maybe anxiety disorders. The current study aims to examine superoxide dismutase (SOD1), catalase, lipid hydroperoxides (LOOH), nitric oxide metabolites (NOx), advanced oxidation protein products (AOPP), malondialdehyde (MDA), glutathione (GSH), paraoxonase 1 (PON1), high-density lipoprotein cholesterol (HDL), and uric acid (UA) in participants with and without generalized anxiety disorder (GAD) co-occurring or not with BD, MDD, or tobacco use disorder. Z unit-weighted composite scores were computed as indices of nitro-oxidative stress driving lipid and protein oxidation. SOD1, LOOH, NOx, and uric acid were significantly higher and HDL and PON1 significantly lower in participants with GAD than in those without GAD. GAD was more adequately predicted by increased SOD + LOOH + NOx and lowered HDL + PON1 composite scores. Composite scores of nitro-oxidative stress coupled with aldehyde and AOPP production were significantly increased in participants with comorbid GAD + MDD as compared with all other study groups, namely MDD, GAD + BD, BD, GAD, and healthy controls. In conclusion, GAD is characterized by increased nitro-oxidative stress and lipid peroxidation and lowered lipid-associated antioxidant defenses, while increased uric acid levels in GAD may protect against aldehyde production and protein oxidation. This study suggests that increased nitro-oxidative stress and especially increased SOD1 activity, NO production, and lipid peroxidation as well as lowered HDL-cholesterol and PON1 activity could be novel drug targets for GAD especially when comorbid with MDD.pt_BR
dc.language.isoenpt_BR
dc.publisherNeurotoxicity Researchpt_BR
dc.subjectBipolar Disorderpt_BR
dc.subjectAnsiedadept_BR
dc.subjectAnxietypt_BR
dc.subjectTrastorno Bipolarpt_BR
dc.titleGeneralized anxiety disorder (GAD) and comorbid major depression with GAD are characterized by enhanced nitro-oxidative stress, increased lipid peroxidation, and lowered lipid-associated antioxidant defensespt_BR
dc.typeArtigo de Periódicopt_BR
Aparece nas coleções:PPGSP - Artigo publicado em revista científica

Arquivos associados a este item:
Arquivo Descrição TamanhoFormato 
2018_art_mmaes.pdf1,05 MBAdobe PDFVisualizar/Abrir


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.